Table of Contents 1 Transdermal Testosterone Market Overview 1.1 Product Overview and Scope of Transdermal Testosterone 1.2 Transdermal Testosterone Segment by Type 1.2.1 Global Transdermal Testosterone Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Gel 1.2.3 Patch 1.2.4 Solution 1.3 Transdermal Testosterone Segment by Application 1.3.1 Transdermal Testosterone Sales Comparison by Application: 2020 VS 2026 1.3.2 Primary hypogonadism 1.3.3 Hypogonadotropic hypogonadism 1.3.4 Late-onset hypogonadism 1.4 Global Transdermal Testosterone Market Size Estimates and Forecasts 1.4.1 Global Transdermal Testosterone Revenue 2015-2026 1.4.2 Global Transdermal Testosterone Sales 2015-2026 1.4.3 Transdermal Testosterone Market Size by Region: 2020 Versus 2026 2 Global Transdermal Testosterone Market Competition by Manufacturers 2.1 Global Transdermal Testosterone Sales Market Share by Manufacturers (2015-2020) 2.2 Global Transdermal Testosterone Revenue Share by Manufacturers (2015-2020) 2.3 Global Transdermal Testosterone Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Transdermal Testosterone Manufacturing Sites, Area Served, Product Type 2.5 Transdermal Testosterone Market Competitive Situation and Trends 2.5.1 Transdermal Testosterone Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Transdermal Testosterone Players (Opinion Leaders) 3 Transdermal Testosterone Retrospective Market Scenario by Region 3.1 Global Transdermal Testosterone Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Transdermal Testosterone Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Transdermal Testosterone Market Facts & Figures by Country 3.3.1 North America Transdermal Testosterone Sales by Country 3.3.2 North America Transdermal Testosterone Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Transdermal Testosterone Market Facts & Figures by Country 3.4.1 Europe Transdermal Testosterone Sales by Country 3.4.2 Europe Transdermal Testosterone Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Transdermal Testosterone Market Facts & Figures by Region 3.5.1 Asia Pacific Transdermal Testosterone Sales by Region 3.5.2 Asia Pacific Transdermal Testosterone Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Transdermal Testosterone Market Facts & Figures by Country 3.6.1 Latin America Transdermal Testosterone Sales by Country 3.6.2 Latin America Transdermal Testosterone Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Transdermal Testosterone Market Facts & Figures by Country 3.7.1 Middle East and Africa Transdermal Testosterone Sales by Country 3.7.2 Middle East and Africa Transdermal Testosterone Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Transdermal Testosterone Historic Market Analysis by Type 4.1 Global Transdermal Testosterone Sales Market Share by Type (2015-2020) 4.2 Global Transdermal Testosterone Revenue Market Share by Type (2015-2020) 4.3 Global Transdermal Testosterone Price Market Share by Type (2015-2020) 4.4 Global Transdermal Testosterone Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Transdermal Testosterone Historic Market Analysis by Application 5.1 Global Transdermal Testosterone Sales Market Share by Application (2015-2020) 5.2 Global Transdermal Testosterone Revenue Market Share by Application (2015-2020) 5.3 Global Transdermal Testosterone Price by Application (2015-2020) 6 Company Profiles and Key Figures in Transdermal Testosterone Business 6.1 AbbVie 6.1.1 Corporation Information 6.1.2 AbbVie Description, Business Overview and Total Revenue 6.1.3 AbbVie Transdermal Testosterone Sales, Revenue and Gross Margin (2015-2020) 6.1.4 AbbVie Products Offered 6.1.5 AbbVie Recent Development 6.2 Teva 6.2.1 Teva Transdermal Testosterone Production Sites and Area Served 6.2.2 Teva Description, Business Overview and Total Revenue 6.2.3 Teva Transdermal Testosterone Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Teva Products Offered 6.2.5 Teva Recent Development 6.3 Perrigo 6.3.1 Perrigo Transdermal Testosterone Production Sites and Area Served 6.3.2 Perrigo Description, Business Overview and Total Revenue 6.3.3 Perrigo Transdermal Testosterone Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Perrigo Products Offered 6.3.5 Perrigo Recent Development 6.4 Endo Pharmaceuticals 6.4.1 Endo Pharmaceuticals Transdermal Testosterone Production Sites and Area Served 6.4.2 Endo Pharmaceuticals Description, Business Overview and Total Revenue 6.4.3 Endo Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Endo Pharmaceuticals Products Offered 6.4.5 Endo Pharmaceuticals Recent Development 6.5 Acerus Pharmaceuticals 6.5.1 Acerus Pharmaceuticals Transdermal Testosterone Production Sites and Area Served 6.5.2 Acerus Pharmaceuticals Description, Business Overview and Total Revenue 6.5.3 Acerus Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Acerus Pharmaceuticals Products Offered 6.5.5 Acerus Pharmaceuticals Recent Development 6.6 Lupin 6.6.1 Lupin Transdermal Testosterone Production Sites and Area Served 6.6.2 Lupin Description, Business Overview and Total Revenue 6.6.3 Lupin Transdermal Testosterone Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Lupin Products Offered 6.6.5 Lupin Recent Development 6.7 Dr. Reddy's Laboratories 6.6.1 Dr. Reddy's Laboratories Transdermal Testosterone Production Sites and Area Served 6.6.2 Dr. Reddy's Laboratories Description, Business Overview and Total Revenue 6.6.3 Dr. Reddy's Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Dr. Reddy's Laboratories Products Offered 6.7.5 Dr. Reddy's Laboratories Recent Development 6.8 Upsher-Smith Laboratories 6.8.1 Upsher-Smith Laboratories Transdermal Testosterone Production Sites and Area Served 6.8.2 Upsher-Smith Laboratories Description, Business Overview and Total Revenue 6.8.3 Upsher-Smith Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Upsher-Smith Laboratories Products Offered 6.8.5 Upsher-Smith Laboratories Recent Development 6.9 Allergan 6.9.1 Allergan Transdermal Testosterone Production Sites and Area Served 6.9.2 Allergan Description, Business Overview and Total Revenue 6.9.3 Allergan Transdermal Testosterone Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Allergan Products Offered 6.9.5 Allergan Recent Development 6.10 Cipla Inc. 6.10.1 Cipla Inc. Transdermal Testosterone Production Sites and Area Served 6.10.2 Cipla Inc. Description, Business Overview and Total Revenue 6.10.3 Cipla Inc. Transdermal Testosterone Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Cipla Inc. Products Offered 6.10.5 Cipla Inc. Recent Development 7 Transdermal Testosterone Manufacturing Cost Analysis 7.1 Transdermal Testosterone Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Transdermal Testosterone 7.4 Transdermal Testosterone Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Transdermal Testosterone Distributors List 8.3 Transdermal Testosterone Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Transdermal Testosterone Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Transdermal Testosterone by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Transdermal Testosterone by Type (2021-2026) 10.2 Transdermal Testosterone Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Transdermal Testosterone by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Transdermal Testosterone by Application (2021-2026) 10.3 Transdermal Testosterone Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Transdermal Testosterone by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Transdermal Testosterone by Region (2021-2026) 10.4 North America Transdermal Testosterone Estimates and Projections (2021-2026) 10.5 Europe Transdermal Testosterone Estimates and Projections (2021-2026) 10.6 Asia Pacific Transdermal Testosterone Estimates and Projections (2021-2026) 10.7 Latin America Transdermal Testosterone Estimates and Projections (2021-2026) 10.8 Middle East and Africa Transdermal Testosterone Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Transdermal Testosterone Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Transdermal Testosterone Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Transdermal Testosterone Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Transdermal Testosterone Manufacturers Covered in This Study Table 5. Global Transdermal Testosterone Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Transdermal Testosterone Sales Share by Manufacturers (2015-2020) Table 7. Global Transdermal Testosterone Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Transdermal Testosterone Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Transdermal Testosterone Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Transdermal Testosterone Sales Sites and Area Served Table 11. Manufacturers Transdermal Testosterone Product Types Table 12. Global Transdermal Testosterone Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Transdermal Testosterone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Testosterone as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Transdermal Testosterone Players Table 16. Global Transdermal Testosterone Sales (K MT) by Region (2015-2020) Table 17. Global Transdermal Testosterone Sales Market Share by Region (2015-2020) Table 18. Global Transdermal Testosterone Revenue (Million US$) by Region (2015-2020) Table 19. Global Transdermal Testosterone Revenue Market Share by Region (2015-2020) Table 20. North America Transdermal Testosterone Sales by Country (2015-2020) (K MT) Table 21. North America Transdermal Testosterone Sales Market Share by Country (2015-2020) Table 22. North America Transdermal Testosterone Revenue by Country (2015-2020) (US$ Million) Table 23. North America Transdermal Testosterone Revenue Market Share by Country (2015-2020) Table 24. Europe Transdermal Testosterone Sales by Country (2015-2020) (K MT) Table 25. Europe Transdermal Testosterone Sales Market Share by Country (2015-2020) Table 26. Europe Transdermal Testosterone Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Transdermal Testosterone Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Transdermal Testosterone Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Transdermal Testosterone Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Transdermal Testosterone Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Transdermal Testosterone Revenue Market Share by Region (2015-2020) Table 32. Latin America Transdermal Testosterone Sales by Country (2015-2020) (K MT) Table 33. Latin America Transdermal Testosterone Sales Market Share by Country (2015-2020) Table 34. Latin America Transdermal Testosterone Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Transdermal Testosterone Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Transdermal Testosterone Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Transdermal Testosterone Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Transdermal Testosterone Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Transdermal Testosterone Revenue Market Share by Country (2015-2020) Table 40. Global Transdermal Testosterone Sales (K MT) by Type (2015-2020) Table 41. Global Transdermal Testosterone Sales Share by Type (2015-2020) Table 42. Global Transdermal Testosterone Revenue (Million US$) by Type (2015-2020) Table 43. Global Transdermal Testosterone Revenue Share by Type (2015-2020) Table 44. Global Transdermal Testosterone Price (USD/MT) by Type (2015-2020) Table 45. Global Transdermal Testosterone Sales (K MT) by Application (2015-2020) Table 46. Global Transdermal Testosterone Sales Market Share by Application (2015-2020) Table 47. Global Transdermal Testosterone Sales Growth Rate by Application (2015-2020) Table 48. AbbVie Transdermal Testosterone Corporation Information Table 49. AbbVie Description and Business Overview Table 50. AbbVie Transdermal Testosterone Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. AbbVie Main Product Table 52. AbbVie Recent Development Table 53. Teva Transdermal Testosterone Corporation Information Table 54. Teva Corporation Information Table 55. Teva Transdermal Testosterone Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Teva Main Product Table 57. Teva Recent Development Table 58. Perrigo Transdermal Testosterone Corporation Information Table 59. Perrigo Corporation Information Table 60. Perrigo Transdermal Testosterone Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Perrigo Main Product Table 62. Perrigo Recent Development Table 63. Endo Pharmaceuticals Transdermal Testosterone Corporation Information Table 64. Endo Pharmaceuticals Corporation Information Table 65. Endo Pharmaceuticals Transdermal Testosterone Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Endo Pharmaceuticals Main Product Table 67. Endo Pharmaceuticals Recent Development Table 68. Acerus Pharmaceuticals Transdermal Testosterone Corporation Information Table 69. Acerus Pharmaceuticals Corporation Information Table 70. Acerus Pharmaceuticals Transdermal Testosterone Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Acerus Pharmaceuticals Main Product Table 72. Acerus Pharmaceuticals Recent Development Table 73. Lupin Transdermal Testosterone Corporation Information Table 74. Lupin Corporation Information Table 75. Lupin Transdermal Testosterone Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Lupin Main Product Table 77. Lupin Recent Development Table 78. Dr. Reddy's Laboratories Transdermal Testosterone Corporation Information Table 79. Dr. Reddy's Laboratories Corporation Information Table 80. Dr. Reddy's Laboratories Transdermal Testosterone Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Dr. Reddy's Laboratories Main Product Table 82. Dr. Reddy's Laboratories Recent Development Table 83. Upsher-Smith Laboratories Transdermal Testosterone Corporation Information Table 84. Upsher-Smith Laboratories Corporation Information Table 85. Upsher-Smith Laboratories Transdermal Testosterone Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 86. Upsher-Smith Laboratories Main Product Table 87. Upsher-Smith Laboratories Recent Development Table 88. Allergan Transdermal Testosterone Corporation Information Table 89. Allergan Corporation Information Table 90. Allergan Transdermal Testosterone Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 91. Allergan Main Product Table 92. Allergan Recent Development Table 93. Cipla Inc. Transdermal Testosterone Corporation Information Table 94. Cipla Inc. Corporation Information Table 95. Cipla Inc. Transdermal Testosterone Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 96. Cipla Inc. Main Product Table 97. Cipla Inc. Recent Development Table 98. Sales Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Transdermal Testosterone Distributors List Table 101. Transdermal Testosterone Customers List Table 102. Market Key Trends Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 104. Key Challenges Table 105. Global Transdermal Testosterone Sales (K MT) Forecast by Type (2021-2026) Table 106. Global Transdermal Testosterone Sales Market Share Forecast by Type (2021-2026) Table 107. Global Transdermal Testosterone Revenue (Million US$) Forecast by Type (2021-2026) Table 108. Global Transdermal Testosterone Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 109. Global Transdermal Testosterone Sales (K MT) Forecast by Application (2021-2026) Table 110. Global Transdermal Testosterone Revenue (Million US$) Forecast by Application (2021-2026) Table 111. Global Transdermal Testosterone Sales (K MT) Forecast by Region (2021-2026) Table 112. Global Transdermal Testosterone Sales Market Share Forecast by Region (2021-2026) Table 113. Global Transdermal Testosterone Revenue Forecast by Region (2021-2026) (US$ Million) Table 114. Global Transdermal Testosterone Revenue Market Share Forecast by Region (2021-2026) Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Transdermal Testosterone Figure 2. Global Transdermal Testosterone Sales Market Share by Type: 2020 VS 2026 Figure 3. Gel Product Picture Figure 4. Patch Product Picture Figure 5. Solution Product Picture Figure 6. Global Transdermal Testosterone Consumption Market Share by Application: 2020 VS 2026 Figure 7. Primary hypogonadism Figure 8. Hypogonadotropic hypogonadism Figure 9. Late-onset hypogonadism Figure 10. Global Transdermal Testosterone Market Size 2015-2026 (US$ Million) Figure 11. Global Transdermal Testosterone Sales Capacity (K MT) (2015-2026) Figure 12. Global Transdermal Testosterone Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Transdermal Testosterone Sales Share by Manufacturers in 2020 Figure 14. Global Transdermal Testosterone Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Transdermal Testosterone Revenue in 2019 Figure 16. Transdermal Testosterone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Transdermal Testosterone Sales Market Share by Region (2015-2020) Figure 18. Global Transdermal Testosterone Sales Market Share by Region in 2019 Figure 19. Global Transdermal Testosterone Revenue Market Share by Region (2015-2020) Figure 20. Global Transdermal Testosterone Revenue Market Share by Region in 2019 Figure 21. North America Transdermal Testosterone Sales Market Share by Country in 2019 Figure 22. North America Transdermal Testosterone Revenue Market Share by Country in 2019 Figure 23. U.S. Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 24. U.S. Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 26. Canada Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Transdermal Testosterone Sales Market Share by Country in 2019 Figure 28. Europe Transdermal Testosterone Revenue Market Share by Country in 2019 Figure 29. Germany Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 30. Germany Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 32. France Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 34. U.K. Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 36. Italy Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 38. Russia Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Transdermal Testosterone Sales Market Share by Region in 2019 Figure 40. Asia Pacific Transdermal Testosterone Revenue Market Share by Region in 2019 Figure 41. China Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 42. China Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 44. Japan Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 46. South Korea Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 48. India Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 50. Australia Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 52. Taiwan Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 54. Indonesia Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 56. Thailand Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 58. Malaysia Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 60. Philippines Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 62. Vietnam Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Transdermal Testosterone Sales Market Share by Country in 2019 Figure 64. Latin America Transdermal Testosterone Revenue Market Share by Country in 2019 Figure 65. Mexico Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 66. Mexico Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 68. Brazil Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 70. Argentina Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Transdermal Testosterone Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Transdermal Testosterone Revenue Market Share by Country in 2019 Figure 73. Turkey Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 74. Turkey Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 76. Saudi Arabia Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. U.A.E Transdermal Testosterone Sales Growth Rate (2015-2020) (K MT) Figure 78. U.A.E Transdermal Testosterone Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Transdermal Testosterone by Type (2015-2020) Figure 80. Sales Market Share of Transdermal Testosterone by Type in 2019 Figure 81. Revenue Share of Transdermal Testosterone by Type (2015-2020) Figure 82. Revenue Market Share of Transdermal Testosterone by Type in 2019 Figure 83. Global Transdermal Testosterone Sales Growth by Type (2015-2020) (K MT) Figure 84. Global Transdermal Testosterone Sales Market Share by Application (2015-2020) Figure 85. Global Transdermal Testosterone Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of Transdermal Testosterone by Application (2015-2020) Figure 87. Global Revenue Share of Transdermal Testosterone by Application in 2020 Figure 88. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Perrigo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Endo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Acerus Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Lupin Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Dr. Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Upsher-Smith Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Allergan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Cipla Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Price Trend of Key Raw Materials Figure 99. Manufacturing Cost Structure of Transdermal Testosterone Figure 100. Manufacturing Process Analysis of Transdermal Testosterone Figure 101. Transdermal Testosterone Industrial Chain Analysis Figure 102. Channels of Distribution Figure 103. Distributors Profiles Figure 104. Porter's Five Forces Analysis Figure 105. North America Transdermal Testosterone Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 106. North America Transdermal Testosterone Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 107. Europe Transdermal Testosterone Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 108. Europe Transdermal Testosterone Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Latin America Transdermal Testosterone Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 110. Latin America Transdermal Testosterone Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Middle East and Africa Transdermal Testosterone Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 112. Middle East and Africa Transdermal Testosterone Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Asia Pacific Transdermal Testosterone Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 114. Asia Pacific Transdermal Testosterone Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Bottom-up and Top-down Approaches for This Report Figure 116. Data Triangulation Figure 117. Key Executives Interviewed

AbbVie Teva Perrigo Endo Pharmaceuticals Acerus Pharmaceuticals Lupin Dr. Reddy's Laboratories Upsher-Smith Laboratories Allergan Cipla Inc.